Surveys queried physicians about their knowledge of and reliance on national prostate cancer screening practice guidelines, use of PSA testing in clinical practice, and knowledge and attitudes regarding the utility of PSA testing for prostate cancer early detection (eTable 1 in Supplement 1). This evidence concerns the gene KLK3 and prostate cancer.